Mayo Clinic researchers reduce inflammation in human cells, a major cause of frailty

Mayo Clinic researchers have discovered that targeting select pathways with JAK inhibitors reduced inflammation in human cells in culture dishes and decreased inflammation and frailty in aged mice. While further studies are needed, researchers are hopeful that these findings will be a step toward treatments for frailty and other age-related chronic conditions.